Reply to "Comment on 'In Vivo Drug Delivery Performance of Lipiodol-Based Emulsion or Drug-Eluting Beads in Patients with Hepatocellular Carcinoma'"

Mol Pharm. 2018 Jan 2;15(1):336-340. doi: 10.1021/acs.molpharmaceut.7b00840. Epub 2017 Dec 1.
No abstract available

Keywords: Lipiodol; doxorubicin; drug-eluting beads; hepatocelluar carcinoma; image-guided transarterial tumor therapy; interventional radiology; liver cancer; local therapy; transarterial chemoembolization (TACE).

Publication types

  • Comment

MeSH terms

  • Antibiotics, Antineoplastic
  • Carcinoma, Hepatocellular*
  • Doxorubicin
  • Emulsions
  • Ethiodized Oil*
  • Humans
  • Liver Neoplasms
  • Treatment Outcome

Substances

  • Antibiotics, Antineoplastic
  • Emulsions
  • Ethiodized Oil
  • Doxorubicin